Global Idarubicin Hydrochloride for Injection Market Research Report 2024

Publication ID:

PB510243387

Publication Date:

October 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Idarubicin Hydrochloride for Injection is a drug used to treat a certain type of cancer (leukemia). It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.
The global Idarubicin Hydrochloride for Injection market was valued at US$ 45.2 million in 2023 and is anticipated to reach US$ 65.1 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
North American market for Idarubicin Hydrochloride for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Idarubicin Hydrochloride for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Idarubicin Hydrochloride for Injection include Pfizer, Hanhui Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Idarubicin Hydrochloride for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idarubicin Hydrochloride for Injection.
The Idarubicin Hydrochloride for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Idarubicin Hydrochloride for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idarubicin Hydrochloride for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Hanhui Pharmaceutical
Nanjing Zhengda Tianqing Pharmaceutical
Segment by Type
5mg/unit
10mg/unit
Segment by Application
Acute Myeloid Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Idarubicin Hydrochloride for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Idarubicin Hydrochloride for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Idarubicin Hydrochloride for Injection Market Overview
1.1 Product Definition
1.2 Idarubicin Hydrochloride for Injection by Type
1.2.1 Global Idarubicin Hydrochloride for Injection Market Value Comparison by Type (2024-2030)
1.2.2 5mg/unit
1.2.3 10mg/unit
1.3 Idarubicin Hydrochloride for Injection by Application
1.3.1 Global Idarubicin Hydrochloride for Injection Market Value by Application (2024-2030)
1.3.2 Acute Myeloid Leukemia (AML)
1.3.3 Acute Lymphoblastic Leukemia (ALL)
1.4 Global Idarubicin Hydrochloride for Injection Market Size Estimates and Forecasts
1.4.1 Global Idarubicin Hydrochloride for Injection Revenue 2019-2030
1.4.2 Global Idarubicin Hydrochloride for Injection Sales 2019-2030
1.4.3 Global Idarubicin Hydrochloride for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Idarubicin Hydrochloride for Injection Market Competition by Manufacturers
2.1 Global Idarubicin Hydrochloride for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Idarubicin Hydrochloride for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Idarubicin Hydrochloride for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Idarubicin Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Idarubicin Hydrochloride for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Idarubicin Hydrochloride for Injection, Product Type & Application
2.7 Global Key Manufacturers of Idarubicin Hydrochloride for Injection, Date of Enter into This Industry
2.8 Global Idarubicin Hydrochloride for Injection Market Competitive Situation and Trends
2.8.1 Global Idarubicin Hydrochloride for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Idarubicin Hydrochloride for Injection Players Market Share by Revenue
2.8.3 Global Idarubicin Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Idarubicin Hydrochloride for Injection Market Scenario by Region
3.1 Global Idarubicin Hydrochloride for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Idarubicin Hydrochloride for Injection Sales by Region: 2019-2030
3.2.1 Global Idarubicin Hydrochloride for Injection Sales by Region: 2019-2024
3.2.2 Global Idarubicin Hydrochloride for Injection Sales by Region: 2025-2030
3.3 Global Idarubicin Hydrochloride for Injection Revenue by Region: 2019-2030
3.3.1 Global Idarubicin Hydrochloride for Injection Revenue by Region: 2019-2024
3.3.2 Global Idarubicin Hydrochloride for Injection Revenue by Region: 2025-2030
3.4 North America Idarubicin Hydrochloride for Injection Market Facts & Figures by Country
3.4.1 North America Idarubicin Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Idarubicin Hydrochloride for Injection Sales by Country (2019-2030)
3.4.3 North America Idarubicin Hydrochloride for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Idarubicin Hydrochloride for Injection Market Facts & Figures by Country
3.5.1 Europe Idarubicin Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Idarubicin Hydrochloride for Injection Sales by Country (2019-2030)
3.5.3 Europe Idarubicin Hydrochloride for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Idarubicin Hydrochloride for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Idarubicin Hydrochloride for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Idarubicin Hydrochloride for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Idarubicin Hydrochloride for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Idarubicin Hydrochloride for Injection Market Facts & Figures by Country
3.7.1 Latin America Idarubicin Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Idarubicin Hydrochloride for Injection Sales by Country (2019-2030)
3.7.3 Latin America Idarubicin Hydrochloride for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Idarubicin Hydrochloride for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Idarubicin Hydrochloride for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Idarubicin Hydrochloride for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Idarubicin Hydrochloride for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Idarubicin Hydrochloride for Injection Sales by Type (2019-2030)
4.1.1 Global Idarubicin Hydrochloride for Injection Sales by Type (2019-2024)
4.1.2 Global Idarubicin Hydrochloride for Injection Sales by Type (2025-2030)
4.1.3 Global Idarubicin Hydrochloride for Injection Sales Market Share by Type (2019-2030)
4.2 Global Idarubicin Hydrochloride for Injection Revenue by Type (2019-2030)
4.2.1 Global Idarubicin Hydrochloride for Injection Revenue by Type (2019-2024)
4.2.2 Global Idarubicin Hydrochloride for Injection Revenue by Type (2025-2030)
4.2.3 Global Idarubicin Hydrochloride for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Idarubicin Hydrochloride for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Idarubicin Hydrochloride for Injection Sales by Application (2019-2030)
5.1.1 Global Idarubicin Hydrochloride for Injection Sales by Application (2019-2024)
5.1.2 Global Idarubicin Hydrochloride for Injection Sales by Application (2025-2030)
5.1.3 Global Idarubicin Hydrochloride for Injection Sales Market Share by Application (2019-2030)
5.2 Global Idarubicin Hydrochloride for Injection Revenue by Application (2019-2030)
5.2.1 Global Idarubicin Hydrochloride for Injection Revenue by Application (2019-2024)
5.2.2 Global Idarubicin Hydrochloride for Injection Revenue by Application (2025-2030)
5.2.3 Global Idarubicin Hydrochloride for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Idarubicin Hydrochloride for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Idarubicin Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Idarubicin Hydrochloride for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Hanhui Pharmaceutical
6.2.1 Hanhui Pharmaceutical Company Information
6.2.2 Hanhui Pharmaceutical Description and Business Overview
6.2.3 Hanhui Pharmaceutical Idarubicin Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hanhui Pharmaceutical Idarubicin Hydrochloride for Injection Product Portfolio
6.2.5 Hanhui Pharmaceutical Recent Developments/Updates
6.3 Nanjing Zhengda Tianqing Pharmaceutical
6.3.1 Nanjing Zhengda Tianqing Pharmaceutical Company Information
6.3.2 Nanjing Zhengda Tianqing Pharmaceutical Description and Business Overview
6.3.3 Nanjing Zhengda Tianqing Pharmaceutical Idarubicin Hydrochloride for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nanjing Zhengda Tianqing Pharmaceutical Idarubicin Hydrochloride for Injection Product Portfolio
6.3.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Idarubicin Hydrochloride for Injection Industry Chain Analysis
7.2 Idarubicin Hydrochloride for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Idarubicin Hydrochloride for Injection Production Mode & Process
7.4 Idarubicin Hydrochloride for Injection Sales and Marketing
7.4.1 Idarubicin Hydrochloride for Injection Sales Channels
7.4.2 Idarubicin Hydrochloride for Injection Distributors
7.5 Idarubicin Hydrochloride for Injection Customers
8 Idarubicin Hydrochloride for Injection Market Dynamics
8.1 Idarubicin Hydrochloride for Injection Industry Trends
8.2 Idarubicin Hydrochloride for Injection Market Drivers
8.3 Idarubicin Hydrochloride for Injection Market Challenges
8.4 Idarubicin Hydrochloride for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Hanhui Pharmaceutical
Nanjing Zhengda Tianqing Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂